Sands Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$355M |
| 2 |
Atlassian
TEAM
|
+$155M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$149M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$142M |
| 5 |
Align Technology
ALGN
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$483M |
| 2 |
Meta Platforms (Facebook)
META
|
+$395M |
| 3 |
Booking.com
BKNG
|
+$234M |
| 4 |
Baidu
BIDU
|
+$195M |
| 5 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Consumer Discretionary | 23.4% |
| 3 | Healthcare | 21.77% |
| 4 | Communication Services | 15.3% |
| 5 | Financials | 9.58% |
Similar funds
Sands Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, Sands Capital Management held 75 positions worth $28B, down 21% from $35.4B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Sands Capital Management withdrew a net $1.38B in Q4 2018, closing 4 positions and reducing 39 holdings. Its most notable exit was Medidata Solutions, Inc., an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Sands Capital Management opened a new position in Match Group worth $330M.
- Sands Capital Management's largest Q4 2018 buy was Match Group: 7,724,932 shares worth $330M.
- Sands Capital Management added most to Atlassian in Q4 2018, an estimated $155M increase.
- Sands Capital Management's biggest Q4 2018 reduction was Charles Schwab, cutting an estimated $483M.
- Sands Capital Management fully exited Medidata Solutions, Inc. in Q4 2018, selling an estimated $157M.
- Sands Capital Management's ten largest holdings make up 53% of its $28B portfolio in Q4 2018.
- Sands Capital Management opened 7 new positions and closed 4 in Q4 2018.
- Sands Capital Management's portfolio value fell 21% quarter-over-quarter to $28B.
Based on Sands Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.